Trump does have some powerful tools that would not require approval from U.S. Congress.Politicsread more
GlaxoSmithKline PLC: "We don't care where a stock's been, we care where it's going, but it is at $37. It's got a 5 percent yield. [CEO] Emma Walmsley is supposed to be doing a good job. I have not seen what I'd like to see from that company. As far as I'm concerned, there are much better drug stocks to own than Glaxo."
SiteOne Landscape Supply Inc.: "No. You don't want to be there because people don't like housing right now and it's going to be affiliated with the housing group and it just keeps going down. We're going to have to take a big pass."
Abbott Laboratories: "Boy, I think that that one is terrific. That's [CEO] Miles White. He's done a remarkable job. The device business is red-hot. They've got a fantastic balance sheet and it's a big holding of the ActionAlertsPlus.com club."
Disclosure: Cramer's charitable trust owns shares of Abbott Laboratories.